Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
canertinib (CI-1033)
i
Other names:
CI-1033, PD 183805
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Pfizer
Drug class:
pan-HER inhibitor
Related drugs:
‹
dacomitinib (32)
FCN-411 (4)
Z650 (2)
AC480 (0)
JRF103 (0)
dacomitinib (32)
FCN-411 (4)
Z650 (2)
AC480 (0)
JRF103 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
GDF15 overexpression
Oral Cancer
GDF15 overexpression
Oral Cancer
CI-1033
Sensitive: D – Preclinical
CI-1033
Sensitive
:
D
CI-1033
Sensitive: D – Preclinical
CI-1033
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login